Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry

BACKGROUND: Oral anticoagulation (OAC) in atrial fibrillation (AF) reduces the risk of stroke/systemic embolism (SE). The impact of OAC discontinuation is less well documented. OBJECTIVE: Investigate outcomes of patients prospectively enrolled in the Global Anticoagulant Registry in the Field‐Atrial...

Descripción completa

Detalles Bibliográficos
Autores principales: Cools, Frank, Johnson, Dana, Camm, Alan J., Bassand, Jean‐Pierre, Verheugt, Freek W. A., Yang, Shu, Tsiatis, Anastasios, Fitzmaurice, David A., Goldhaber, Samuel Z., Kayani, Gloria, Goto, Shinya, Haas, Sylvia, Misselwitz, Frank, Turpie, Alexander G. G., Fox, Keith A. A., Pieper, Karen S., Kakkar, Ajay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
VASCULAR BIOLOGY
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390436/
https://www.ncbi.nlm.nih.gov/pubmed/34060704
http://dx.doi.org/10.1111/jth.15415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390436/
https://www.ncbi.nlm.nih.gov/pubmed/34060704
http://dx.doi.org/10.1111/jth.15415

Ejemplares similares